Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Intravenous Neonatal Central Access Safety Trial

NCT: NCT05537389 · RECRUITING

NCT IDNCT05537389
StatusRECRUITING
Start Date2023-01-01
Completion2026-06-30

Brief Summary

Particulate contamination due to infusion therapy (administration of parenteral nutrition and medications) carries a potential health risk for infants in neonatal intensive care units (NICU). In-line filtration is increasingly used in critically-ill infants but its benefits, by preventing micro-particle infusion in neonates, remain to be demonstrated. In-line filters in the intravenous administration sets prevent the infusion of particles, which may reduce infectious complications.

Frequently Asked Questions

What is Intravenous Neonatal Central Access Safety Trial?

Intravenous Neonatal Central Access Safety Trial is a clinical trial registered under NCT05537389. Current status: RECRUITING.

What is the status of NCT05537389?

The current status of NCT05537389 (Intravenous Neonatal Central Access Safety Trial) is: RECRUITING.

When did Intravenous Neonatal Central Access Safety Trial start?

Intravenous Neonatal Central Access Safety Trial started on 2023-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.